INO
Inovio Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
3.12 / 10Overall Score
NeturalInvestment Rating
3.12 / 10Overall Score
NeturalInvestment Rating
Is INO a Good Buy Right Now?
- Based on a composite score of 3.12/10, we rate INO as a Netural. Our analysis breaks down into 3.51/10 for Fundamentals, 1.25/10 for Technicals, and 3.86/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of INO?
Is INO undervalued or overvalued?
Is money flowing into or out of INO?
Is INO a Good Buy Right Now?
- Based on a composite score of 3.12/10, we rate INO as a Netural. Our analysis breaks down into 3.51/10 for Fundamentals, 1.25/10 for Technicals, and 3.86/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is INO undervalued or overvalued?
Technical Analysis of INO?
Is money flowing into or out of INO?
